» Articles » PMID: 39551647

Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire

Overview
Publisher Elsevier
Specialty Geriatrics
Date 2024 Nov 17
PMID 39551647
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To improve assessment of neuropsychiatric symptoms (NPS) by expanding the measurement properties of the Neuropsychiatric Inventory Questionnaire (NPI-Q).

Design: Multicenter, longitudinal observational study.

Setting: Several Alzheimer's Disease Research Centers (ADRCs).

Participants: Individuals (n = 45,274) who presented to an ADRC with a collateral and completed the NPI-Q.

Measurements: The NPI-Q total severity score, four NPI-Q subscales, dementia stage, expert NPS rating, consensus rating of dementia syndrome, global cognitive screening, collateral rating of daily functioning, and self-rating of depression.

Results: There was strong evidence of criterion validity with both dementia stage and expert NPS rating for the NPI-Q total severity index, which informed cutoffs and interpretive ranges. Furthermore, subscales had adequate classification of dementia syndromes and appropriate convergent relationships with cognition, daily functioning, and mood. There was good-to-excellent evidence of reliability for the NPI-Q total severity index over several years, and subscales had adequate-to-good reliability.

Conclusions: This is the first study to provide empirically established cutoffs, interpretive ranges, and evidence of reliability over a period longer than a month on the NPI-Q and its subscales. This will improve assessment of NPS in clinical and research contexts.

Article Summary: Neuropsychiatric symptoms of neurodegeneration are increasingly understood as early disease markers with tremendous functional impact later in disease, but are often missed or misdiagnosed. The most common measure of these symptoms, the Neuropsychiatric Inventory Questionnaire (NPI-Q), does not have clinically actionable guidance, which this article provided. We established cutscores for several conditions and test-retest reliability over longer periods for the total score and subscales using a multicenter database.

Citing Articles

The potential of depressive symptoms to identify cognitive impairment in ageing.

Alexopoulos P, Bountoulis C, Katirtzoglou E, Kosmidis M, Siarkos K, Yannakoulia M Eur J Ageing. 2025; 22(1):7.

PMID: 40000465 PMC: 11861444. DOI: 10.1007/s10433-025-00837-1.

References
1.
McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

2.
Aarsland D, Bronnick K, Ehrt U, De Deyn P, Tekin S, Emre M . Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2006; 78(1):36-42. PMC: 2117797. DOI: 10.1136/jnnp.2005.083113. View

3.
Mokkink L, Terwee C, Patrick D, Alonso J, Stratford P, Knol D . The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010; 63(7):737-45. DOI: 10.1016/j.jclinepi.2010.02.006. View

4.
. 2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024; 20(5):3708-3821. PMC: 11095490. DOI: 10.1002/alz.13809. View

5.
Fischer C, Ismail Z, Schweizer T . Delusions increase functional impairment in Alzheimer's disease. Dement Geriatr Cogn Disord. 2012; 33(6):393-9. DOI: 10.1159/000339954. View